𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The roles of cys124 and ser239 in the functional properties of human βIII tubulin

✍ Scribed by Joe, Patrick A. ;Banerjee, Asok ;Ludueña, Richard F.

Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
337 KB
Volume
65
Category
Article
ISSN
0886-1544

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Tubulin is the target for some very powerful anti‐mitotic and anti‐tumor drugs. The βIII tubulin isotype is found in very few normal tissues, but is often found in tumors, where it has been implicated in resistance to anti‐tumor drugs. The βIII isotype occurs in fish, amphibians, birds and mammals and its unique features are highly conserved in evolution. One of these features is the replacement of cys239 by ser239. Cys239 is unusual in being highly sensitive to oxidation; in fact, oxidation of this residue inhibits microtubule assembly. The βIII isotype also has a very unusual cys124, where other β isotypes have ser/ala124. The striking conservation in βIII of vertebrates strongly suggests that cys124 and ser239 play functional roles. We have prepared the C124S and S239C mutants of βIII and tested their effects on the functional properties of tubulin. We have found that both the βIII C124S and βIII S239C mutants bind colchicine less well than does wild‐type αβIII, and also make transfected HeLa cells more resistant to colchicine. However, the double mutant, βIII C124S/S239C, binds colchicine still less well than do either of the single mutants, but in contrast to the former, the double mutant increases the cells' sensitivity to colchicine. Our results indicate that the roles that these residues play in colchicine binding and microtubule integrity are far more complex than previously imagined and that the specific residues at which βIII differs from the other isotypes act collectively to keep βIII in a functional conformation. Cell Motil. Cytoskeleton 2008. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Tubulin targets in the pathobiology and
Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. class III β-tubulin
✍ Christos D. Katsetos; Eduarda Dráberová; Agustin Legido; Charles Dumontet; Pavel 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 625 KB

## Abstract Glioblastoma multiforme (GBM) is the most common and deadliest form of primary brain cancer in adults. Despite advances in molecular biology and genetics of gliomas currently there is no effective treatment or promising molecularly targeted experimental therapeutic strategies for these

Mutational analysis of the class I β-tub
Mutational analysis of the class I β-tubulin gene in human breast cancer
✍ Seiichi Hasegawa; Yasuo Miyoshi; Chiyomi Egawa; Makoto Ishitobi; Yasuhiro Tamaki 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 244 KB

Non-small cell lung cancers have a high incidence of somatic mutations of the beta-tubulin (class I) gene, suggesting involvement in the acquisition of resistance to taxanes, which exert their effects through binding to beta-tubulin. Since taxanes are often used in the treatment of breast cancer, we

Class III β-Tubulin isotype (β III) in t
Class III β-Tubulin isotype (β III) in the adrenal medulla: III. Differential expression of neuronal and glial antigens identifies two distinct populations of neuronal and glial-like (sustentacular) cells in the PC12 rat pheochromocytoma cell line maintained in a gelfoam matrix system
✍ Katsetos, Christos D. ;Herman, Mary M. ;Balin, Brian J. ;Vinores, Stanley A. ;He 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 755 KB

## Background: The rat PC12 pheochromocytoma cell line provides an established system for the study of neuronal differentiation. To our knowledge, glial differentiation has not been reported in this cell line. Methods: We have studied, by immunohistochemistry and immunoblotting, the presence of n